1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow Bellerophon: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| 3 Part Study to Assess Inhaled Nitric Oxide on Functional Pulmonary Imaging in Subj. Pulmonary Hypertension Associated w/ COPD and IPF inhaled Nitric Oxide - 30 mcg/kg IBW/hr, inhaled Nitric Oxide 5,10,15 mcg/Kg IBW/hr, inhaled nitric oxide 75 mcg/kg IBW/hr - Pulmonary Hypertension, Chronic Obstructive Pulmonary Disease | Phase 1 | Completed | Bellerophon | 8 | 2015-05-01 | 2023-02-21 |
Hypertension, Pulmonary (1) · Idiopathic Pulmonary Fibrosis (1) · Pulmonary Disease, Chronic Obstructive (1)
Belgium (1)
Ashika Ahmed (1)